Page 21 - Read Online
P. 21

Umetsu et al. Hepatoma Res 2020;6:1  I  http://dx.doi.org/10.20517/2394-5079.2019.030                                          Page 9 of 10


               Ethical approval and consent to participate
               The institutional review board of Saiseikai Yokohama-shi Tobu Hospital approved, and informed consent
               was obtained from parent.

               Consent to participate
               Written informed consent was obtained from the guardian of the patients for publication of this Case
               report and any accompanying images. A copy of the written consent is available for review by the Editor of
               this journal.


               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain
                   2003;126:1905-12.
               2.   Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, et al. Clinical and molecular features of mitochondrial DNA depletion
                   syndromes. J Inherit Metab Dis 2009;32:143-58.
               3.   Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-8.
               4.   Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D’Adamo P, et al. MPV17 encodes an inner mitochondrial membrane
                   protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-5.
               5.   Spinazzola A, Santer R, Akman OH, Tsiakas K, Schaefer H, et al. Hepatocerebral form of mitochondrial DNA depletion syndrome:
                   novel MPV17 mutations. Arch Neurol 2008;65:1108-13.
               6.   Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 2001;106:4-17.
               7.   Ferrari G, Lamantea E, Donati A, Filosto M, Briem E, et al. Infantile hepatocerebral syndromes associated with mutations in the
                   mitochondrial DNA polymerase-gammaA. Brain 2005;128:723-31.
               8.   Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, et al. Recessive Twinkle mutations in early onset encephalopathy with
                   mtDNA depletion. Brain 2007;130:3032-40.
               9.   Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted
                   hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-41.
               10.  Karadimas CL, Vu TH, Holve SA, Chronopoulou P, Quinzii C, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17
                   gene. Am J Hum Genet 2006;79:544-8.
               11.  Parini R, Furlan F, Notarangelo L, Spinazzola A, Uziel G, et al. Glucose metabolism and diet-based prevention of liver dysfunction in
                   MPV17 mutant patients. J Hepatol 2009;50:215-21.
               12.  Wong LJ, Brunetti-Pierri N, Zhang Q, Yazigi N, Bove KE, et al. Mutations in the MPV17 gene are responsible for rapidly progressive
                   liver failure in infancy. Hepatology 2007;46:1218-27.
               13.  Navarro-Sastre A, Martin-Hernandez E, Campos Y, Quintana E, Medina E, et al. Lethal hepatopathy and leukodystrophy caused by a
                   novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab 2008;94:234-9.
               14.  Kaji S, Murayama K, Nagata I, Nagasaka H, Takayanagi M, et al. Fluctuating liver functions in siblings with MPV17 mutations and
                   possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II. Mol Genet Metab
                   2009;97:292-6.
               15.  El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, et al. MPV17-associated hepatocerebral mitochondrial DNA depletion
                   syndrome: new patients and novel mutations. Mol Genet Metab 2010;99:300-8.
               16.  Merkle AN, Nascene DR, McKinney AM. MR imaging findings in the reticular formation in siblings with MPV17-related
                   mitochondrial depletion syndrome. AJNR Am J Neuroradiol 2012;33:E34-5.
               17.  Al-Jasmi F, Penefsky HS, Souid AK. The phosphorescence oxygen analyzer as a screening tool for disorders with impaired
                   lymphocyte bioenergetics. Mol Genet Metab 2011;104:529-36.
               18.  AlSaman A, Tomoum H, Invernizzi F, Zeviani M. Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in
                   MPV17 gene. Saudi J Gastroenterol 2012;18:285-9.
               19.  Nogueira C, de Souza CF, Husny A, Derks TG, Santorelli FM, et al. MPV17: fatal hepatocerebral presentation in a Brazilian infant.
                   Mol Genet Metab 2012;107:764.
               20.  Uusimaa J, Evans J, Smith C, Butterworth A, Craig K, et al. Clinical, biochemical, cellular and molecular characterization of
                   mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene. Eur J Hum Genet 2014;22:184-91.
               21.  Piekutowska-Abramczuk D, Pronicki M, Strawa K, Karkucinska-Wieckowska A, Szymanska-Debinska T, et al. Novel c.191C>G
                   (p.Pro64Arg) MPV17 mutation identified in two pairs of unrelated Polish siblings with mitochondrial hepatoencephalopathy. Clin
                   Genet 2014;85:573-7.
               22.  Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, et al. Adult-onset fatal neurohepatopathy in a woman caused by
                   MPV17 mutation. JIMD Rep 2014;13:37-41.
               23.  Al-Hussaini A, Faqeih E, El-Hattab AW, Alfadhel M, Asery A, et al. Clinical and molecular characteristics of mitochondrial DNA
                   depletion syndrome associated with neonatal cholestasis and liver failure. J Pediatr 2014;164:553-9.e1-2.
   16   17   18   19   20   21   22   23   24   25   26